The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children
- 1 August 2006
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 25 (1), 14-18
- https://doi.org/10.1016/j.vaccine.2006.07.020
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectivenessThe Lancet, 2006
- Bacille Calmette-Guerin Vaccine--Induced Disease in HIV-Infected and HIV-Uninfected ChildrenClinical Infectious Diseases, 2006
- A review of vaccine research and development: TuberculosisVaccine, 2005
- Danish Bacille Calmette-Guerin Vaccine-Induced Disease in Human Immunodeficiency Virus-Infected ChildrenClinical Infectious Diseases, 2003
- Criteria for Identification of Cross-Contamination of Cultures of Mycobacterium tuberculosis in Routine Microbiology LaboratoriesJournal of Clinical Microbiology, 2003
- BCG vaccine effectiveness in preventing tuberculosis and its interaction with human immunodeficiency virus infectionInternational Journal of Epidemiology, 2000
- Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Côte dʼIvoireAIDS, 1997
- Immunological conditions of children with BCG disseminated infectionThe Lancet, 1995
- Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-AnalysisInternational Journal of Epidemiology, 1993
- Bacillus Calmette—Guérin immunization in infants born to HIV-1-seropositive mothersAIDS, 1991